The new clinical practice guideline (CPG) is intended to complement and extend existing guidelines available in the literature, including previous CPGs from AACE.

• The new document advocates a comprehensive approach to routine diabetes management, based on evidence that, although glycemia control variables such as HbA1c and glucose excursions have an impact on cardiovascular disease risk, other factors – including obesity, blood pressure, dyslipidemia, and hypercoagulation – also play important roles.
• The goals for these guidelines are to provide the health care professional with tools to develop a comprehensive care plan for the prevention and management of diabetes and its complications, addressing not just hyperglycemia, but all associated cardiovascular risk factors.
• The document advocates an individualized approach to treatment, with personalized goals based on duration of diabetes, comorbidities, longevity, and the ability to provide treatment safely.
• In addition to Type 2 diabetes, the CPG also addresses the care of individuals with pre-diabetes, Type 1 diabetes, children/adolescents and pregnant women with diabetes, and hospitalized patients with hyperglycemia.
• Controversies in diabetes care, such as new diagnostic criteria of diabetes, medication, and surgical treatment are also included, as are new technologies such as insulin pumps and continuous glucose monitoring.
• Less familiar areas such as sleep and breathing disturbances and depression are also addressed.
• These state-of-the-art guidelines provide the most up to date evidence-based answers to real-life questions to enable the health care provider to deliver the most relevant, individualized treatment plan for patients with diabetes.

Read More on  http://www.internalmedicinenews.com/single-view/new-aace-guidelines-emphasize-comprehensive-diabetes-management/8602092ac6.html